In bladder cancer, Teng et al. constructed a risk score based on tumor-infiltrating immune cell (TIIC) characteristics by using multiple machine learning algorithms together with single-cell data to evaluate patients' responses to PD-L1 therapy and their prognosis [52]. This evidence concerns the gene CD274 and urinary bladder cancer.